Effects of Energy Drinks on Cardiovascular Endpoints
Evaluation of Energy Drinks on Electrocardiographic Parameters: A Randomized, Double Blind, Controlled, Crossover, Proof-of-concept Study
University of the Pacific
3 participants
Nov 1, 2025
INTERVENTIONAL
Conditions
Summary
This is a clinical trial looking at the impact of energy drinks on heart related parameters. The study will enroll 3 participants who will be exposed to 8 different interventions.
Eligibility
Plain Language Summary
Simplified for easier understanding
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
1000 mL caffeine- and taurine-containing commercially available beverage (Formula A) consumed with placebo capsule
Placebo drink with 400 mg moxifloxacin capsule
Placebo drink with 320 mg caffeine capsule
Placebo drink with placebo capsule
568 mL caffeine- and taurine-containing commercially available beverage (Formula B)
Control product with 4000 mg taurine powder
Control product with 320 mg caffeine + 4000 mg taurine powder
591 mL caffeine- and taurine-containing commercially available beverage (Formula A)
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07212803